Navidea Biopharmaceuticals, Inc (NAVB) Financials
Stock symbol NAVB is outdated, potentially delisted? Maybe it is available on other exchange?
NAVB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 5.7 million | 8.7 million |
| June 30, 2023 | 8.2 million | 9.0 million |
| March 31, 2023 | 2.4 million | 11.9 million |
| Dec. 31, 2022 | 4.4 million | 12.5 million |
NAVB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -10.3 million | 10347 |
| June 30, 2023 | 4.6 million | -33842 |
| March 31, 2023 | -1.8 million | 19669 |
| Dec. 31, 2022 | -2.5 million | 34895 |
NAVB Net Income
No data available :(
NAVB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 3.9 million | - | 10696 |
| June 30, 2023 | 6.1 million | - | 19564 |
| March 31, 2023 | 33795 | - | 11298 |
| Dec. 31, 2022 | 2.0 million | - | 20288 |
NAVB Shares Outstanding
NAVB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 16523 | 829613 | 1.3 million | - |
| June 30, 2023 | 65337 | 1.1 million | 1.3 million | - |
| March 31, 2023 | 39409 | 1.3 million | 1.2 million | - |
| Dec. 31, 2022 | 72039 | 1.9 million | 1.3 million | - |
NAVB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | - |
| June 30, 2023 | - | - |
| March 31, 2023 | - | - |
| Dec. 31, 2022 | 610 | 50036 |
NAVB
Price: $0
52 week price:
Earnings Per Share: -0.20 USD
P/E Ratio: -0.17
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 89200
Market Capitalization: 3.5 million